Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT00098228

Last Updated: 2011-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

686 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-07-31

Study Completion Date

2004-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple dose inhaler for use in the COPD Phase III program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

QAB149

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of COPD
* Age 40-75 years
* Smoking history

Exclusion Criteria

* Other serious disease
* Allergy to QAB149
* Respiratory tract infection
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novartis Pharmaceuticals

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Novartis East Hanover

Role:

862-778-8300

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UAB Pulmonary Research

Birmingham, Alabama, United States

Site Status

Diagnostic & Medical Clinic

Mobile, Alabama, United States

Site Status

The University of South Alabama Medical Center

Mobile, Alabama, United States

Site Status

Pulmonary Associates

Phoenix, Arizona, United States

Site Status

USC Rancho Amigos Medical Center

Downey, California, United States

Site Status

Radiant Research

Encinitas, California, United States

Site Status

Allergy Research Foundation , Inc

Los Angeles, California, United States

Site Status

David Geffin UCLA School of Medicine

Los Angeles, California, United States

Site Status

Southern California Research

Mission Viejo, California, United States

Site Status

California Allergy & Asthma Medical Group

Palmdale, California, United States

Site Status

Allergy Associates Medical Group, Inc

San Diego, California, United States

Site Status

Allergy & Asthma Associates of Santa Clara Research Center

San Jose, California, United States

Site Status

Bensch Clinical Research Associates

Stockton, California, United States

Site Status

Rocky Mountain Center for Clinical Research

Wheat Ridge, Colorado, United States

Site Status

Physician's Research Center

Hartford, Connecticut, United States

Site Status

University of Miami School of Medicine

Miami, Florida, United States

Site Status

Crescent Clinical Research

Pensacola, Florida, United States

Site Status

Cordova Medical Center

Pensacola, Florida, United States

Site Status

USF Asthma, Allergy & Immunology, Clinical Research Unit

Tampa, Florida, United States

Site Status

University Medical Associates, LLP

Augusta, Georgia, United States

Site Status

Radiant Research - Atlanta West

Austell, Georgia, United States

Site Status

Sneeze, Wheeze & Itch Associates, LLC

Normal, Illinois, United States

Site Status

Asthma and Allergy Center of Chicago S.C.

River Forest, Illinois, United States

Site Status

New Orleans Center for Clinical Research

New Orleans, Louisiana, United States

Site Status

St. Elizabeth's Medical Center

Brighton, Massachusetts, United States

Site Status

Center for Clinical Research

Tauton, Massachusetts, United States

Site Status

ClinSite, Inc.

Ann Arbor, Michigan, United States

Site Status

University of Michigan Health System

Ann Arbor, Michigan, United States

Site Status

Pulmonary Respiratory Institute of Southeast Michigan

Livonia, Michigan, United States

Site Status

Clinical Research Institute

Minneapolis, Minnesota, United States

Site Status

Minnesota Lung Center

Minneapolis, Minnesota, United States

Site Status

The Clinical Research Center

St Louis, Missouri, United States

Site Status

Creigton University

Omaha, Nebraska, United States

Site Status

Univ. of Nebraska Medical Center--Pulmonary Research

Omaha, Nebraska, United States

Site Status

New England Clinical Research

North Dartmouth, New Hampshire, United States

Site Status

Princeton Center for Clinical Research

Skillman, New Jersey, United States

Site Status

Pulmonary & Allergy Associates

Springfield, New Jersey, United States

Site Status

AAIR Reseach Center

Rochester, New York, United States

Site Status

University of Noth Carolina--Pulmonary Division

Chapel Hill, North Carolina, United States

Site Status

North Carolina Clinical Research

Raleigh, North Carolina, United States

Site Status

Cloverdale Research Facility

Winston-Salem, North Carolina, United States

Site Status

Oklahoma Allergy and Asthma Clinic

Oklahoma City, Oklahoma, United States

Site Status

VA Medical Center

Oklahoma City, Oklahoma, United States

Site Status

Healthcare Research Consultants Inc.

Tulsa, Oklahoma, United States

Site Status

River Road Medical Group

Eugene, Oregon, United States

Site Status

Allergy Associates Research Center

Portland, Oregon, United States

Site Status

Low Country Lung and Critical Care

Charleston, South Carolina, United States

Site Status

Upstate Pharmaceutical Research

Simpsonville, South Carolina, United States

Site Status

Asthma & Allergy Res. Associates

Dallas, Texas, United States

Site Status

Central Texas Health Research

New Baunfels, Texas, United States

Site Status

Sylvana Research

San Antonio, Texas, United States

Site Status

Trinity Clinic Office of Research Admin.

Tyler, Texas, United States

Site Status

Madrona Medical Group

Bellingham, Washington, United States

Site Status

Pulmonary Consultants, PLLC

Tacoma, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CQAB149B2205

Identifier Type: -

Identifier Source: org_study_id